News

Self-administration of alpha-1-antitrypsin can significantly improve patients' quality of life

20. 8. 2020 Source: Deficiency of Alpha-1-Antitrypsin

Treatment of alpha-1 antitrypsin deficiency (AATD) requires lifetime administration of weekly intravenous infusions of this substance, mostly in medical facilities. The possibility of AAT application at home is being discussed. This topic was also addressed at a symposium held during the European Respiratory Society (ERS) congress, which took place in November 2019 in Madrid.

Treatment of Glaucoma: Without Preservatives for Everyone?

A comprehensive report by Professor John Thygesen from the University Hospital in Copenhagen analyzes patient groups for whom preservative-free antiglaucoma medications are particularly suitable. In…

20. 8. 2020 Source: Treatment of Glaucoma

Pharmacokinetics and Safety of Bilastine 10 mg in Children Aged 6–11 Years

The second-generation antihistamine bilastine is approved in Europe for the treatment of allergic rhinoconjunctivitis and urticaria from the age of 6 years. Recently, results from two post hoc…

17. 8. 2020 Source: Allergic Reactions

Safety and Tolerability of Bilastine in the Treatment of Chronic Urticaria in Children

Chronic urticaria is less common in pediatric patients compared to the acute form, but it always requires therapy due to bothersome chronic symptoms that reduce quality of life and disrupt daily…

17. 8. 2020 Source: Allergic Reactions

Transition of Hemophilia A Patients with a History of Coagulation Factor Inhibitor to Emicizumab

During the World Federation of Hemophilia (WFH) conference, held virtually in June 2020, interesting results were presented for patients with Hemophilia A who had a history of FVIII inhibitor and are…

3. 8. 2020 Source: Quality Life Even with Hemophilia

DPP-4 Inhibitors May Prevent SARS-CoV-2 Entry into Cells

Since the new type of coronavirus SARS-CoV-2 utilizes the DPP-4 receptor to enter human cells, DPP-4 inhibition by gliptins could represent a potential approach to pharmacological treatment of…

3. 8. 2020 Source: Diabetes

An Introductory Word to the Section on Hereditary Angioedema —⁠ MUDr. Roman Hakl, Ph.D.

Hereditary angioedema (HAE) is a genetically conditioned disease, currently classified into HAE with C1 inhibitor deficiency (HAE-C1-INH), referred to as HAE-I and HAE-II, and HAE with normal level…

29. 7. 2020 Source: Hereditary Angioedema

rozhodnutí_možnosti_vs._nohy_boty_cesta_volba

Algorithm for Choosing Antidiabetics in Patients with Type 2 Diabetes

As of June 1, 2020, general practitioners can prescribe antidiabetics from the group of so-called gliptins, inhibitors of the enzyme dipeptidyl peptidase 4 (DPP-4i), in addition to metformin. The…

29. 7. 2020 Source: Diabetes

Major Orthopedic Procedures in Patients with Inhibitor Treated with Emicizumab

Italian authors presented the results of a study of a small series of hemophilia patients with inhibitors treated with emicizumab, who underwent major orthopedic surgery, at the World Federation of…

28. 7. 2020 Source: Quality Life Even with Hemophilia

Comorbidities of Migraine and Their Impact on Pain Frequency and Intensity

The MAST study, published in March of this year in the prestigious The Journal of Headache and Pain, focused on the occurrence of associated diseases in patients with migraine. What is the prevalence…

27. 7. 2020 Source: Migraine

1 … 142 143 144 145 146 … 171

Back Filter by speciality

Remove filters